Cytokinetics Berita Eulerpool

Cytokinetics Berita Saham

Cytokinetics diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini Cytokinetics kami rangkum di sini.

• 20 Desember ·

  Yahoo
  Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
• 19 Desember ·

  Yahoo
  Calculating The Fair Value Of Cytokinetics, Incorporated (NASDAQ:CYTK)
• 6 Desember ·

  Yahoo
  Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?
• 3 Desember ·

  Yahoo
  Sector Update: Health Care Stocks Mixed Late Afternoon
• 3 Desember ·

  Yahoo
  Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction
• 2 Desember ·

  Yahoo
  Cytokinetics to Participate in December Investor Conferences
• 2 Desember ·

  Yahoo
  Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
• 2 Desember ·

  Yahoo
  Novocure device succeeds in pancreatic cancer study; FDA sets Cytokinetics decision date
• 22 November ·

  Yahoo
  Cytokinetics price target raised to $103 from $99 at Mizuho
• 21 November ·

  Yahoo
  Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?